A growing body of evidence suggests that ApoE4 increases the risk of AD by inhibiting Aβ clearance, promoting Aβ aggregation, and suppressing Aβ cellular uptake and metabolism, although the precise molecular mechanisms remain unclear [80,81,82,83,84,85]. The gene discussed is APOE; the disease is Alzheimer disease.